Choice of surgical procedure for patients with non-small-cell lung cancer ≤ 1 cm or > 1 to 2 cm among lobectomy, segmentectomy, and wedge resection: A population-based study

Journal of Clinical Oncology

Volumn 34, Issue 26, 2016, Pages 3175-3182

  Dai, Chenyang ^a   Shen, Jianfei ^c   Ren, Yijiu ^a   Zhong, Shengyi ^c   Zheng, Hui ^a   He, Jiaxi ^c   Xie, Dong ^a   Fei, Ke ^a   Liang, Wenhua ^c   Jiang, Gening ^a   Yang, Ping ^d   Petersen, Rene Horsleben ^e   Ng, Calvin S H ^f   Liu, Chia Chuan ^g   Rocco, Gaetano ^h   Brunelli, Alessandro ⁱ   Shen, Yaxing ^b   Chen, Chang ^a   He, Jianxing ^c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d Mayo Clinic College of Medicine   (United States)

^e University of Copenhagen   (Denmark)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g Sun Yat Sen Cancer Center   (Taiwan)

^h NATIONAL CANCER INSTITUTE   (Italy)

ⁱ ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEGMENTECTOMY; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME; WEDGE RESECTION; ADVERSE EFFECTS; CANCER REGISTRY; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CHI SQUARE DISTRIBUTION; CLINICAL DECISION MAKING; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LUNG NEOPLASMS; LUNG RESECTION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PATIENT SELECTION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TIME FACTOR; UNITED STATES;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; CLINICAL DECISION-MAKING; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; UNITED STATES;

EID: 84989899950     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.64.6729     Document Type: Article

References (29)

1. Aberle DR, Adams AM, Berg CD, et al: Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395-409, 2011
2. Ginsberg RJ, Rubinstein LV; Lung Cancer Study Group: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 60:615-622, 1995; discussion 622-623
3. Zhong C, Fang W, Mao T, et al: Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy for small-sized stage IA lung cancer. Ann Thorac Surg 94:362-367, 2012
4. Wisnivesky JP, Henschke CI, Swanson S, et al: Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg 251:550-554, 2010
5. Rami-Porta R, Bolejack V, Crowley J, et al: The IASLC lung cancer staging project: Proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 10:990-1003, 2015
6. National Cancer Institute: Surveillance, Epidemiology, and End Results. http://www.seer.cancer.gov
7. Timmerman R D, Paulus R, Pass H I, et al: RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients. J Clin Oncol 31:7523, 2013
8. Nagata Y, Hiraoka M, Shibata T, et al: A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG0403). Int J Radiat Oncol Biol Phys 78:S27-S28, 2010 (suppl)
9. Chang J Y, Senan S, Paul M A, et al: Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials. Lancet Oncol 16:630-637, 2015
10. Verma V: Stereotactic radiotherapy versus surgery for early-stage operable lung cancer: More questions than answers. J Natl Compr Canc Netw 13:1293-1295, 2015
11. Nieder C, Andratschke NH, Guckenberger M: A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: Is failure to recruit patients into randomized trials also an answer to the research question? Ann Transl Med 3:148, 2015
12. Cao C, D'Amico T, Demmy T, et al: Surgery versus SABR for resectable non-small-cell lung cancer. Lancet Oncol 16:e370-e371, 2015
13. Yendamuri S, Sharma R, Demmy M, et al: Temporal trends in outcomes following sublobar and lobar resections for small (≤ 2 cm) non-small-cell lung cancers: A Surveillance Epidemiology End Results database analysis. J Surg Res 183:27-32, 2013
14. Wolf AS, Richards WG, Jaklitsch MT, et al: Lobectomy versus sublobar resection for small (2 cm or less) non-small-cell lung cancers. Ann Thorac Surg 92:1819-1823, 2011; discussion 1824-1825
15. Zhang Y, Sun Y, Wang R, et al: Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small-cell lung cancer. J Surg Oncol 111:334-340, 2015
16. Miller DL, Rowland CM, Deschamps C, et al: Surgical treatment of non-small-cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 73:1545-1550, 2002; discussion 1550-1551
17. Jiang W, Pang X, Xi J, et al: Clinical outcome of subcentimeter non-small-cell lung cancer after surgical resection: Single institution experience of 105 patients. J Surg Oncol 110:233-238, 2014
18. Schuchert MJ, Kilic A, Pennathur A, et al: Oncologic outcomes after surgical resection of subcentimeter non-small cell lung cancer. Ann Thorac Surg 91:1681-1687, 2011; discussion 1687-1688
19. Kates M, Swanson S, Wisnivesky JP: Survival following lobectomy and limited resection for the treatment of stage I non-small-cell lung cancer<=1 cm in size: A review of SEER data. Chest 139:491-496, 2011
20. Khullar O V, Liu Y, Gillespie T, et al: Survival after sublobar resection versus lobectomy for clinical stage IA lung cancer: An analysis from the National Cancer Data Base. J Thorac Oncol 10:1625-1633, 2015
21. Sihoe AD, Van Schil P: Non-small-cell lung cancer: When to offer sublobar resection. Lung Cancer 86:115-120, 2014
22. Sienel W, Dango S, Kirschbaum A, et al: Sublobar resections in stage IA non-small-cell lung cancer: Segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg 33:728-734, 2008
23. Smith CB, Swanson SJ, Mhango G, et al: Survival after segmentectomy and wedge resection in stage I non-small-cell lung cancer. J Thorac Oncol 8:73-78, 2013
24. Koike T, Koike T, Yoshiya K, et al: Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small-cell lung cancer. J Thorac Cardiovasc Surg 146:372-378, 2013
25. Blasberg JD, Pass HI, Donington JS: Sublobar resection: A movement from the Lung Cancer Study Group. J Thorac Oncol 5:1583-1593, 2010
26. Tsutani Y, Miyata Y, Nakayama H, et al: Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study. J Thorac Cardiovasc Surg 143:607-612, 2012
27. Maeyashiki T, Suzuki K, Hattori A, et al: The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer. Eur J Cardiothorac Surg 43:915-918, 2013
28. Hung JJ, Yeh YC, Jeng WJ, et al: Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival. J Clin Oncol 32:2357-2364, 2014
29. Lee MC, Kadota K, Buitrago D, et al: Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: Results from international and Chinese cohorts. J Thorac Dis 6:S568-S580, 2014